Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance.

Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, Havrilesky L, Secord AA, Moore DT, Gehrig PA, Bae-Jump VL.

Gynecol Oncol. 2014 Apr;133(1):28-32. doi: 10.1016/j.ygyno.2014.01.032.

PMID:
24680588
2.

The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma.

Elshaikh MA, Munkarah AR, Robbins JR, Laser BS, Bhatt N, Cogan C, Siddiqui F.

Gynecol Oncol. 2013 Feb;128(2):171-4. doi: 10.1016/j.ygyno.2012.10.016.

PMID:
23103929
3.

Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women.

Mahdi H, Hou H, Kowk LL, Moslemi-Kebria M, Michener C.

Gynecol Oncol. 2014 Jun;133(3):512-7. doi: 10.1016/j.ygyno.2014.03.562.

PMID:
24674830
4.

A GOG 210 aCGH study of gain at 1q23 in endometrioid endometrial cancer in the context of racial disparity and outcome.

Morrison C, Miecznikowski J, Darcy KM, Dolce JM, Kandel E, Erwin DO, Liu S, Shepherd L, Cohn D, McMeekin DS, Block AW, Nowak NJ, Maxwell L.

Genes Chromosomes Cancer. 2010 Sep;49(9):791-802. doi: 10.1002/gcc.20782.

PMID:
20607851
5.

Endometrial cancer in morbidly obese women: do racial disparities affect surgical or survival outcomes?

Cote ML, Ruterbusch JJ, Ahmed Q, Bandyopadhyay S, Alosh B, Abdulfatah E, Seward S, Morris R, Ali-Fehmi R.

Gynecol Oncol. 2014 Apr;133(1):38-42. doi: 10.1016/j.ygyno.2014.01.013.

6.

The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.

Cote ML, Ruterbusch JJ, Olson SH, Lu K, Ali-Fehmi R.

Cancer Epidemiol Biomarkers Prev. 2015 Sep;24(9):1407-15. doi: 10.1158/1055-9965.EPI-15-0316.

7.

Metformin is associated with improved survival in endometrial cancer.

Ko EM, Walter P, Jackson A, Clark L, Franasiak J, Bolac C, Havrilesky LJ, Secord AA, Moore DT, Gehrig PA, Bae-Jump V.

Gynecol Oncol. 2014 Feb;132(2):438-42. doi: 10.1016/j.ygyno.2013.11.021.

PMID:
24269517
8.

Comparison of survival outcomes between patients with malignant mixed mullerian tumors and high-grade endometrioid, clear cell, and papillary serous endometrial cancers.

Felix AS, Stone RA, Bowser R, Chivukula M, Edwards RP, Weissfeld JL, Linkov F.

Int J Gynecol Cancer. 2011 Jul;21(5):877-84. doi: 10.1097/IGC.0b013e31821a62dd.

9.

Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.

AlHilli MM, Mariani A, Bakkum-Gamez JN, Dowdy SC, Weaver AL, Peethambaram PP, Keeney GL, Cliby WA, Podratz KC.

Gynecol Oncol. 2014 Jun;133(3):485-93. doi: 10.1016/j.ygyno.2014.03.567.

10.

The influence of comorbid conditions on racial disparities in endometrial cancer survival.

Ruterbusch JJ, Ali-Fehmi R, Olson SH, Sealy-Jefferson S, Rybicki BA, Hensley-Alford S, Elshaikh MA, Gaba AR, Schultz D, Munkarah AR, Cote ML.

Am J Obstet Gynecol. 2014 Dec;211(6):627.e1-9. doi: 10.1016/j.ajog.2014.06.036.

11.

Adjuvant therapy in stage III endometrial cancer: treatment outcomes and survival. a single-institution retrospective study.

Kuku S, Williams M, McCormack M.

Int J Gynecol Cancer. 2013 Jul;23(6):1056-64. doi: 10.1097/IGC.0b013e3182978328.

PMID:
23765205
12.

The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.

Vance S, Yechieli R, Cogan C, Hanna R, Munkarah A, Elshaikh MA.

Gynecol Oncol. 2012 Jul;126(1):16-9. doi: 10.1016/j.ygyno.2012.04.011.

PMID:
22507535
13.

Endometrial cancer in Asian and American Indian/Alaskan Native women: tumor characteristics, treatment and outcome compared to non-Hispanic white women.

Mahdi H, Schlick CJ, Kowk LL, Moslemi-Kebria M, Michener C.

Gynecol Oncol. 2014 Feb;132(2):443-9. doi: 10.1016/j.ygyno.2013.11.028.

PMID:
24316310
14.

[Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].

Gottwald L, Chałubińska J, Moszyńska-Zielińska M, Piekarski J, Tyliński W, Szwalski J, Kubiak R, Pasz-Walczak G, Hendzel K, Ciałkowska-Rysz A.

Ginekol Pol. 2011 Oct;82(10):743-8. Polish.

PMID:
22379937
15.

Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.

Rauh-Hain JA, Hariton E, Clemmer J, Clark RM, Hall T, Boruta DM, Schorge JO, Del Carmen MG.

Obstet Gynecol. 2015 Jun;125(6):1362-70. doi: 10.1097/AOG.0000000000000866.

PMID:
26000507
16.

Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.

Elshaikh MA, Vance S, Suri JS, Mahan M, Munkarah A.

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):351-6. doi: 10.1016/j.ijrobp.2013.11.003.

PMID:
24411608
17.

Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.

Matthews RP, Hutchinson-Colas J, Maiman M, Fruchter RG, Gates EJ, Gibbon D, Remy JC, Sedlis A.

Gynecol Oncol. 1997 May;65(2):206-12.

PMID:
9159326
18.

Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.

Amant F, Cadron I, Fuso L, Berteloot P, de Jonge E, Jacomen G, Van Robaeys J, Neven P, Moerman P, Vergote I.

Gynecol Oncol. 2005 Aug;98(2):274-80.

PMID:
15972232
19.

Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.

Canlorbe G, Bendifallah S, Raimond E, Graesslin O, Hudry D, Coutant C, Touboul C, Bleu G, Collinet P, Darai E, Ballester M.

Ann Surg Oncol. 2015 Aug;22(8):2714-21. doi: 10.1245/s10434-014-4295-0.

PMID:
25503347
20.

Management of aggressive histologic variants of endometrial carcinoma at the Tom Baker Cancer Centre between 1984 and 1994.

Craighead PS, Sait K, Stuart GC, Arthur K, Nation J, Duggan M, Guo D.

Gynecol Oncol. 2000 May;77(2):248-53.

PMID:
10785473
Items per page

Supplemental Content

Support Center